Ajai Chari

I'm your host, Brian Topping.

Today's episode features Dr. Jesus Berdeja from the Greco Haynesworth Centers for Research at Tennessee Oncology in Nashville, Tennessee, and Dr. Ajai Chari from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, as they discuss key topics in managing patients with newly diagnosed multiple myeloma, including u- optimal use of bortezomib, the role of transplantation in the quadruplet era, and novel maintenance therapies.

This episode is part of a larger educational program titled Advances in Multiple Myeloma: Patient and Expert Insights into- on Translating the Latest Breakthroughs into Equitable Care.

For more information, along with a link to the larger education program, please visit the show notes for this episode.